Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0592
+0.0074 (14.29%)
Sep 17, 2025, 3:53 PM EDT
Oncotelic Therapeutics Employees
Oncotelic Therapeutics had 26 employees as of December 31, 2024. The number of employees increased by 4 or 18.18% compared to the previous year.
Employees
26
Change (1Y)
4
Growth (1Y)
18.18%
Revenue / Employee
n/a
Profits / Employee
-$151,011
Market Cap
25.92M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 26 | 4 | 18.18% |
Dec 31, 2023 | 22 | 0 | - |
Dec 31, 2022 | 22 | 6 | 37.50% |
Dec 31, 2021 | 16 | 0 | - |
Dec 31, 2020 | 16 | 3 | 23.08% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
CytoDyn | 13 |
Silence Therapeutics | 116 |
Oncotelic Therapeutics News
- 1 day ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments - GlobeNewsWire
- 5 days ago - Oncotelic Therapeutics Highlights 2 Years of Clinical and Regulatory Advancements Across Late-Stage Pipeline - GlobeNewsWire
- 7 days ago - IBN Initiates Coverage of Oncotelic Therapeutics Inc. - GlobeNewsWire
- 13 days ago - Dr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics' Commitment to Innovation, Life-Saving Therapies - GlobeNewsWire
- 20 days ago - Oncotelic Therapeutics Showcases Robust Pipeline and Founder's Broad Intellectual Property Contributions to Biopharma Industry - GlobeNewsWire
- 6 weeks ago - OTCQB Venture Virtual Investor Conference Agenda Announced for August 7th - GlobeNewsWire
- 2 months ago - SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients - GlobeNewsWire
- 2 months ago - Oncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients - GlobeNewsWire